191 related articles for article (PubMed ID: 35803020)
1. Small molecules enhancers of amyloid aggregation of C-terminal domain of Nucleophosmin 1 in acute myeloid leukemia.
Florio D; Roviello V; La Manna S; Napolitano F; Maria Malfitano A; Marasco D
Bioorg Chem; 2022 Oct; 127():106001. PubMed ID: 35803020
[TBL] [Abstract][Full Text] [Related]
2. Could Targeting NPM1c+ Misfolding Be a Promising Strategy for Combating Acute Myeloid Leukemia?
Florio D; Marasco D
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255885
[TBL] [Abstract][Full Text] [Related]
3. Conformational consequences of NPM1 rare mutations: An aggregation perspective in Acute Myeloid Leukemia.
La Manna S; Florio D; Di Natale C; Napolitano F; Malfitano AM; Netti PA; De Benedictis I; Marasco D
Bioorg Chem; 2021 Aug; 113():104997. PubMed ID: 34044346
[TBL] [Abstract][Full Text] [Related]
4. Type C mutation of nucleophosmin 1 acute myeloid leukemia: Consequences of intrinsic disorder.
La Manna S; Florio D; Di Natale C; Lagreca E; Sibillano T; Giannini C; Marasco D
Biochim Biophys Acta Gen Subj; 2022 Aug; 1866(8):130173. PubMed ID: 35597503
[TBL] [Abstract][Full Text] [Related]
5. Proteostasis unbalance of nucleophosmin 1 in Acute Myeloid Leukemia: An aggregomic perspective.
Di Natale C; Florio D; Di Somma S; Di Matteo A; Federici L; Netti PA; Morelli G; Malfitano AM; Marasco D
Int J Biol Macromol; 2020 Dec; 164():3501-3507. PubMed ID: 32890557
[TBL] [Abstract][Full Text] [Related]
6. Structural insights into amyloid structures of the C-terminal region of nucleophosmin 1 in type A mutation of acute myeloid leukemia.
Di Natale C; La Manna S; Malfitano AM; Di Somma S; Florio D; Scognamiglio PL; Novellino E; Netti PA; Marasco D
Biochim Biophys Acta Proteins Proteom; 2019 Jun; 1867(6):637-644. PubMed ID: 30710643
[TBL] [Abstract][Full Text] [Related]
7. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
[TBL] [Abstract][Full Text] [Related]
8. The acute myeloid leukemia-associated Nucleophosmin 1 gene mutations dictate amyloidogenicity of the C-terminal domain.
La Manna S; Scognamiglio PL; Roviello V; Borbone F; Florio D; Di Natale C; Bigi A; Cecchi C; Cascella R; Giannini C; Sibillano T; Novellino E; Marasco D
FEBS J; 2019 Jun; 286(12):2311-2328. PubMed ID: 30921500
[TBL] [Abstract][Full Text] [Related]
9. Type F mutation of nucleophosmin 1 Acute Myeloid Leukemia: A tale of disorder and aggregation.
La Manna S; Florio D; Di Natale C; Scognamiglio PL; Sibillano T; Netti PA; Giannini C; Marasco D
Int J Biol Macromol; 2021 Oct; 188():207-214. PubMed ID: 34364939
[TBL] [Abstract][Full Text] [Related]
10. Amyloid fibers deriving from the aromatic core of C-terminal domain of nucleophosmin 1.
La Manna S; Roviello V; Scognamiglio PL; Diaferia C; Giannini C; Sibillano T; Morelli G; Novellino E; Marasco D
Int J Biol Macromol; 2019 Feb; 122():517-525. PubMed ID: 30389521
[TBL] [Abstract][Full Text] [Related]
11. Insights into Network of Hot Spots of Aggregation in Nucleophosmin 1.
Florio D; La Manna S; Di Natale C; Leone M; Mercurio FA; Napolitano F; Malfitano AM; Marasco D
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499032
[TBL] [Abstract][Full Text] [Related]
12. Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.
Rau R; Brown P
Hematol Oncol; 2009 Dec; 27(4):171-81. PubMed ID: 19569254
[TBL] [Abstract][Full Text] [Related]
13. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
14. EAPB0503, an Imidazoquinoxaline Derivative Modulates SENP3/ARF Mediated SUMOylation, and Induces NPM1c Degradation in NPM1 Mutant AML.
Skayneh H; Jishi B; Hleihel R; Hamie M; El Hajj R; Deleuze-Masquefa C; Bonnet PA; El Sabban M; El Hajj H
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408798
[TBL] [Abstract][Full Text] [Related]
15. Non-Mutated Nucleophosmin 1 Is Recognized by the CD8+ T Lymphocytes of an AML Patient after the Transplantation of Hematopoietic Stem Cells from an HLA-Haploidentical Donor.
Nemeckova S; Alexova-Zurkova K; Hainz P; Krystofova J; Mackova J; Roubalova K; Stastna-Markova M; Vrana M; Vydra J
Curr Oncol; 2022 Apr; 29(5):2928-2934. PubMed ID: 35621629
[TBL] [Abstract][Full Text] [Related]
16. Nucleophosmin 1: from its pathogenic role to a tantalizing therapeutic target in acute myeloid leukemia.
Shi Y; Xue Y; Wang C; Yu L
Hematology; 2022 Dec; 27(1):609-619. PubMed ID: 35621728
[TBL] [Abstract][Full Text] [Related]
17. Nucleophosmin contains amyloidogenic regions that are able to form toxic aggregates under physiological conditions.
Di Natale C; Scognamiglio PL; Cascella R; Cecchi C; Russo A; Leone M; Penco A; Relini A; Federici L; Di Matteo A; Chiti F; Vitagliano L; Marasco D
FASEB J; 2015 Sep; 29(9):3689-701. PubMed ID: 25977257
[TBL] [Abstract][Full Text] [Related]
18. Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1.
Balusu R; Fiskus W; Rao R; Chong DG; Nalluri S; Mudunuru U; Ma H; Chen L; Venkannagari S; Ha K; Abhyankar S; Williams C; McGuirk J; Khoury HJ; Ustun C; Bhalla KN
Blood; 2011 Sep; 118(11):3096-106. PubMed ID: 21719597
[TBL] [Abstract][Full Text] [Related]
19. The effect of small molecule inhibitor NSC348884 on nucleophosmin 1-mutated acute myeloid leukemia cells.
Zhu JF; Han LL; Ma Y; Wang YX; Zhang F
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9145-9151. PubMed ID: 37843328
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
Falini B
Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
